Literature DB >> 1644931

An intact cysteine-rich domain is required for dystrophin function.

R D Bies1, C T Caskey, R Fenwick.   

Abstract

The carboxyl terminus of dystrophin is encoded by a highly conserved, alternatively spliced region of the gene. The few rare mutations reported in this region are of interest in unraveling the function of the dystrophin molecule. An unusual case of infantile onset Duchenne muscular dystrophy (DMD) with an internal 3' genomic deletion, and a membrane localized non-functional dystrophin protein, was used to explore the functional activity of this region. The patient's cDNA sequence showed an intragenic 1824-bp deletion precisely excising the cysteine rich and alternatively spliced COOH-terminal domains of dystrophin. The unaltered final 2.7 kb of the patients transcript was defined as a single exon localized to two genomic fragments, with the 5.9 kb HindIII fragment containing the stop codon. To understand the significance of deletions in this important region of the dystrophin gene, we mapped the order and cDNA coordinates for the 3' genomic HindIII fragments encoding the cysteine rich and alternative splicing domains. This 3' gene map was used to compare the clinical phenotype of the other reported COOH-terminal deletions in the literature. Our analysis concludes that the cysteine-rich domain confers an important function for the dystrophin protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644931      PMCID: PMC443149          DOI: 10.1172/JCI115909

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.

Authors:  K Arahata; A H Beggs; H Honda; S Ito; S Ishiura; T Tsukahara; T Ishiguro; C Eguchi; S Orimo; E Arikawa
Journal:  J Neurol Sci       Date:  1991-02       Impact factor: 3.181

2.  Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies.

Authors:  J Chelly; H Gilgenkrantz; M Lambert; G Hamard; P Chafey; D Récan; P Katz; A de la Chapelle; M Koenig; I B Ginjaar
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

3.  Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?

Authors:  D Récan; P Chafey; F Leturcq; J P Hugnot; N Vincent; F Tomé; H Collin; D Simon; P Czernichow; L V Nicholson
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

4.  Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes.

Authors:  R G Roberts; T F Barby; E Manners; M Bobrow; D R Bentley
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

5.  Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development.

Authors:  R D Bies; S F Phelps; M D Cortez; R Roberts; C T Caskey; J S Chamberlain
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

6.  Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA.

Authors:  R G Roberts; D R Bentley; T F Barby; E Manners; M Bobrow
Journal:  Lancet       Date:  1990 Dec 22-29       Impact factor: 79.321

7.  Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin.

Authors:  P Y Fong; P R Turner; W F Denetclaw; R A Steinhardt
Journal:  Science       Date:  1990-11-02       Impact factor: 47.728

8.  Expression and localization of dystrophin in human cardiac Purkinje fibers.

Authors:  R D Bies; D Friedman; R Roberts; M B Perryman; C T Caskey
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

9.  Expression of recombinant dystrophin and its localization to the cell membrane.

Authors:  C C Lee; J A Pearlman; J S Chamberlain; C T Caskey
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

10.  Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy.

Authors:  E P Hoffman; C A Garcia; J S Chamberlain; C Angelini; J R Lupski; R Fenwick
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

View more
  16 in total

1.  Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury.

Authors:  Richard M Lovering; Patrick G De Deyne
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-01       Impact factor: 4.249

2.  Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy.

Authors:  Gyula Acsadi; Steven A Moore; Angélique Chéron; Olivier Delalande; Lindsey Bennett; William Kupsky; Mohammad El-Baba; Elisabeth Le Rumeur; Jean-François Hubert
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

3.  Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening.

Authors:  Debra A O'Leary; Orzala Sharif; Paul Anderson; Buu Tu; Genevieve Welch; Yingyao Zhou; Jeremy S Caldwell; Ingo H Engels; Achim Brinker
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

Review 4.  The Dystrophin Complex: Structure, Function, and Implications for Therapy.

Authors:  Quan Q Gao; Elizabeth M McNally
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

5.  Spectrum of small mutations in the dystrophin coding region.

Authors:  T W Prior; C Bartolo; D K Pearl; A C Papp; P J Snyder; M S Sedra; A H Burghes; J R Mendell
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

6.  Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.

Authors:  K Matsumura; F M Tomé; V Ionasescu; J M Ervasti; R D Anderson; N B Romero; D Simon; D Récan; J C Kaplan; M Fardeau
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  The ZZ domain of dystrophin in DMD: making sense of missense mutations.

Authors:  Adeline Vulin; Nicolas Wein; Dana M Strandjord; Eric K Johnson; Andrew R Findlay; Baijayanta Maiti; Michael T Howard; Yuuki J Kaminoh; Laura E Taylor; Tabatha R Simmons; Will C Ray; Federica Montanaro; Jim M Ervasti; Kevin M Flanigan
Journal:  Hum Mutat       Date:  2013-12-02       Impact factor: 4.878

8.  Subtle neuromuscular defects in utrophin-deficient mice.

Authors:  R M Grady; J P Merlie; J R Sanes
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

9.  Forced expression of dystrophin deletion constructs reveals structure-function correlations.

Authors:  J A Rafael; G A Cox; K Corrado; D Jung; K P Campbell; J S Chamberlain
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

10.  A novel DMD intronic alteration: a potentially disease-causing variant of an intermediate muscular dystrophy phenotype.

Authors:  Ricardo Santin; Igor Araujo Vieira; Jean Costa Nunes; Maria Luiza Benevides; Fernanda Quadros; Ana Carolina Brusius-Facchin; Gabriel Macedo; Ana Paula Santin Bertoni
Journal:  Acta Myol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.